SEOUL, South Korea--(BUSINESS WIRE)--DongWha Pharm (KRX:000020), a leading Korean pharmaceutical company, announced on April 21 st, 2020 that it plans to conduct clinical trials using a new drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback